title: Discordant results obtained with Francisella tularensis during in vitro and in vivo immunological studies are attributable to compromised bacterial structural integrity.
abstract: Francisella tularensis (Ft) is a highly infectious intracellular pathogen and the causative agent of tularemia. Because Ft can be dispersed via small droplet-aerosols and has a very low infectious dose it is characterized as a category A Select Agent of biological warfare. Respiratory infection with the attenuated Live Vaccine Strain (LVS) and the highly virulent SchuS4 strain of Ft engenders intense peribronchiolar and perivascular inflammation, but fails to elicit select pro-inflammatory mediators (e.g., TNF, IL-1β, IL-6, IL-12, and IFN-γ) within the first ~72 h. This in vivo finding is discordant with the principally TH1-oriented response to Ft frequently observed in cell-based studies wherein the aforementioned cytokines are produced. An often overlooked confounding factor in the interpretation of experimental results is the influence of environmental cues on the bacterium's capacity to elicit certain host responses. Herein, we reveal that adaptation of Ft to its mammalian host imparts an inability to elicit select pro-inflammatory mediators throughout the course of infection. Furthermore, in vitro findings that non-host adapted Ft elicits such a response from host cells reflect aberrant recognition of the DNA of structurally-compromised bacteria by AIM2-dependent and -independent host cell cytosolic DNA sensors. Growth of Ft in Muller-Hinton Broth or on Muller-Hinton-based chocolate agar plates or genetic mutation of Ft was found to compromise the structural integrity of the bacterium thus rendering it capable of aberrantly eliciting pro-inflammatory mediators (e.g., TNF, IL-1β, IL-6, IL-12, and IFN-γ). Our studies highlight the profound impact of different growth conditions on host cell response to infection and demonstrate that not all in vitro-derived findings may be relevant to tularemia pathogenesis in the mammalian host. Rational development of a vaccine and immunotherapeutics can only proceed from a foundation of knowledge based upon in vitro findings that recapitulate those observed during natural infection.
authors.affiliation: Center for Immunology and Microbial Disease, Albany Medical College, Albany, New York, USA.
authors.forename: Anju
authors.initials: A
authors.lastname: Singh
authors.forename: Tabassum
authors.initials: T
authors.lastname: Rahman
authors.forename: Meenakshi
authors.initials: M
authors.lastname: Malik
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Hickey
authors.forename: Cynthia A
authors.initials: CA
authors.lastname: Leifer
authors.forename: Karsten R O
authors.initials: KR
authors.lastname: Hazlett
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Sellati
mesh_terms: D000818:Animals; D001428:Bacterial Vaccines / Q000276:immunology / Q000494:pharmacology; D016207:Cytokines / Q000276:immunology*; D005604:Francisella tularensis / Q000276:immunology* / Q000472:pathogenicity; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D051379:Mice; D018345:Mice, Knockout; D012141:Respiratory Tract Infections / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D014406:Tularemia / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D014613:Vaccines, Attenuated / Q000276:immunology / Q000494:pharmacology
chemical_list: D001428:Bacterial Vaccines; D016207:Cytokines; D014613:Vaccines, Attenuated
references.citation: J Biol Chem. 1999 Nov 19;274(47):33419-25
references.pmid: 10559223
references.citation: Infect Immun. 2006 May;74(5):2809-16
references.pmid: 16622218
references.citation: J Infect Dis. 2007 Jul 1;196(1):134-7
references.pmid: 17538893
references.citation: J Biol Chem. 2008 Feb 15;283(7):3751-60
references.pmid: 18079113
references.citation: Nat Immunol. 2006 Oct;7(10):1066-73
references.pmid: 16980981
references.citation: Pharm Res. 1996 Sep;13(9):1367-72
references.pmid: 8893276
references.citation: J Immunol. 2010 Sep 1;185(5):2670-4
references.pmid: 20679532
references.citation: Proc Natl Acad Sci U S A. 2010 May 25;107(21):9771-6
references.pmid: 20457908
references.citation: Cell Microbiol. 2011 Oct;13(10):1586-600
references.pmid: 21883803
references.citation: Microb Pathog. 2006 Dec;41(6):218-25
references.pmid: 16996713
references.citation: J Leukoc Biol. 2011 Sep;90(3):493-507
references.pmid: 21724804
references.citation: J Leukoc Biol. 2006 Oct;80(4):766-73
references.pmid: 16895974
references.citation: PLoS One. 2011;6(7):e22335
references.pmid: 21799828
references.citation: Front Microbiol. 2011 Feb 16;2:26
references.pmid: 21687418
references.citation: Proc Natl Acad Sci U S A. 2002 May 28;99(11):7681-6
references.pmid: 12032343
references.citation: Nat Immunol. 2010 May;11(5):395-402
references.pmid: 20351692
references.citation: Immunol Lett. 2007 Oct 15;112(2):92-103
references.pmid: 17764754
references.citation: J Immunol. 2007 Apr 1;178(7):4538-47
references.pmid: 17372012
references.citation: J Biol Chem. 2004 Nov 26;279(48):49995-50003
references.pmid: 15465827
references.citation: Infect Immun. 2007 Nov;75(11):5338-45
references.pmid: 17785474
references.citation: Nat Immunol. 2010 May;11(5):385-93
references.pmid: 20351693
references.citation: Infect Immun. 2008 Oct;76(10):4479-88
references.pmid: 18644878
references.citation: J Immunol. 2002 Oct 15;169(8):4088-93
references.pmid: 12370334
references.citation: J Biol Chem. 2010 Sep 3;285(36):27553-60
references.pmid: 20558723
references.citation: Infect Immun. 2007 Aug;75(8):4127-37
references.pmid: 17517865
references.citation: Infect Immun. 2006 Jun;74(6):3657-62
references.pmid: 16714598
references.citation: Front Cell Infect Microbiol. 2012 Oct 11;2:126
references.pmid: 23087911
references.citation: Microb Pathog. 2007 May-Jun;42(5-6):204-14
references.pmid: 17369012
references.citation: J Immunol. 2010 Jun 1;184(11):6386-95
references.pmid: 20421641
references.citation: Exp Cell Res. 2005 Aug 1;308(1):1-17
references.pmid: 15896773
references.citation: J Immunol. 2005 Nov 15;175(10):6792-801
references.pmid: 16272336
references.citation: J Bacteriol. 2009 Nov;191(22):6855-64
references.pmid: 19749055